WallStSmart

Coca-Cola European Partners PLC (CCEP)vsCoca-Cola Consolidated Inc. (COKE)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Coca-Cola European Partners PLC generates 196% more annual revenue ($20.90B vs $7.07B). CCEP leads profitability with a 9.3% profit margin vs 8.7%. CCEP appears more attractively valued with a PEG of 2.85. COKE earns a higher WallStSmart Score of 59/100 (C).

CCEP

Buy

57

out of 100

Grade: C

Growth: 8.0Profit: 6.5Value: 7.3Quality: 5.5
Piotroski: 3/9Altman Z: 1.55

COKE

Buy

59

out of 100

Grade: C

Growth: 6.7Profit: 7.5Value: 7.3Quality: 6.3
Piotroski: 3/9Altman Z: 2.82
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CCEPUndervalued (+57.3%)

Margin of Safety

+57.3%

Fair Value

$228.38

Current Price

$96.08

$132.30 discount

UndervaluedFair: $228.38Overvalued
COKEUndervalued (+50.3%)

Margin of Safety

+50.3%

Fair Value

$320.22

Current Price

$212.85

$107.37 discount

UndervaluedFair: $320.22Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCEP4 strengths · Avg: 8.8/10
EPS GrowthGrowth
68.3%10/10

Earnings expanding 68.3% YoY

Return on EquityProfitability
22.9%9/10

Every $100 of equity generates 23 in profit

Revenue GrowthGrowth
20.0%8/10

Revenue surging 20.0% year-over-year

Free Cash FlowQuality
$1.51B8/10

Generating 1.5B in free cash flow

COKE2 strengths · Avg: 9.0/10
Return on EquityProfitability
41.9%10/10

Every $100 of equity generates 42 in profit

EPS GrowthGrowth
24.3%8/10

Earnings expanding 24.3% YoY

Areas to Watch

CCEP4 concerns · Avg: 3.0/10
Altman Z-ScoreHealth
1.554/10

Distress zone — elevated risk

Debt/EquityHealth
1.503/10

Elevated debt levels

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
2.852/10

Expensive relative to growth rate

COKE3 concerns · Avg: 3.0/10
Price/BookValuation
11.2x4/10

Trading at 11.2x book value

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
3.042/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : CCEP

The strongest argument for CCEP centers on EPS Growth, Return on Equity, Revenue Growth. Revenue growth of 20.0% demonstrates continued momentum.

Bull Case : COKE

The strongest argument for COKE centers on Return on Equity, EPS Growth.

Bear Case : CCEP

The primary concerns for CCEP are Altman Z-Score, Debt/Equity, Piotroski F-Score.

Bear Case : COKE

The primary concerns for COKE are Price/Book, Piotroski F-Score, PEG Ratio.

Key Dynamics to Monitor

CCEP profiles as a growth stock while COKE is a value play — different risk/reward profiles.

COKE carries more volatility with a beta of 0.64 — expect wider price swings.

CCEP is growing revenue faster at 20.0% — sustainability is the question.

CCEP generates stronger free cash flow (1.5B), providing more financial flexibility.

Bottom Line

COKE scores higher overall (59/100 vs 57/100). CCEP offers better value entry with a 57.3% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Coca-Cola European Partners PLC

CONSUMER DEFENSIVE · BEVERAGES - NON-ALCOHOLIC · USA

Coca-Cola Europacific Partners PLC produces, distributes and sells a variety of ready-to-drink non-alcoholic beverages. The company is headquartered in Uxbridge, the United Kingdom.

Coca-Cola Consolidated Inc.

CONSUMER DEFENSIVE · BEVERAGES - NON-ALCOHOLIC · USA

Coca-Cola Consolidated, Inc. produces, markets and distributes non-alcoholic beverages primarily products of The Coca-Cola Company in the United States. The company is headquartered in Charlotte, North Carolina.

Want to dig deeper into these stocks?